Stockscreener 앱 받기
0.00%
시간 외 거래:
Geron Corp 주식(GERN)의 최신 뉴스
Travel Stocks: What margin trends mean for Geron Corporation stockTrade Performance Summary & Technical Analysis for Trade Confirmation - moha.gov.vn
Geron (GERN) Plans Restructuring to Cut Costs, H.C. Wainwright Stays Neutral - Finviz
Geron extends loan agreement deadlines for $250 million credit facility - Investing.com
Geron extends loan agreement deadlines for $250 million credit facility By Investing.com - Investing.com UK
Geron Signs Loan Agreement Amendment With BioPharma Credit - TradingView — Track All Markets
Geron Corporation (NASDAQ:GERN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Geron (NASDAQ:GERN) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat
Geron (NASDAQ:GERN) Trading Up 4.9%Time to Buy? - MarketBeat
Geron Corporation (GERN) restructuring to lower operating expenses as it eyes profitability in 2026 - MSN
How Geron Corporation stock compares to market leadersJuly 2025 Price Swings & Precise Buy Zone Identification - Улправда
Can Geron Corporation (GON) stock expand revenue streamsWeekly Trade Report & Smart Investment Allocation Insights - Улправда
What margin trends mean for Geron Corporation stock2025 Volatility Report & Weekly High Potential Alerts - Улправда
Geron: From Launch Hype To Later-Line Gravity (NASDAQ:GERN) - Seeking Alpha
Geron (NASDAQ:GERN) Shares Down 3.9%What's Next? - MarketBeat
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation (GERN) Restructuring to Lower Operating Expenses as it Eyes Profitability in 2026 - Yahoo Finance
Geron (NASDAQ:GERN) Stock Price Up 5.6%Here's What Happened - MarketBeat
14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey
Geron Corporation (NASDAQ: GERN) plans workforce cuts, expects $18M charges - Stock Titan
Squarepoint Ops LLC Increases Stock Position in Geron Corporation $GERN - MarketBeat
Geron strategic restructuring plan focuses on Rytelo growth (GERN:NASDAQ) - Seeking Alpha
Bay Area biotech company, down $1.7 billion in value, lays off a third of staff - SFGATE
Geron (NASDAQ:GERN) Trading Up 8.2%What's Next? - MarketBeat
Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025) - ts2.tech
Geron stock falls as H.C. Wainwright reiterates Neutral rating amid restructuring - Investing.com
Praxis tees up another approval filing; Geron turns to layoffs - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Nasdaq Composite ETF Clinical Trials - Kalkine Media
Geron Corporation (NASDAQ:GERN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting - Finviz
Foster City drug maker Geron to lay off one-third of staff under new CEOSan Francisco Business Times - The Business Journals
Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On Sidelines (GERN) - Seeking Alpha
Geron Corporation (GERN) Announces Significant Workforce Reducti - GuruFocus
Geron (GERN) Initiates Strategic Restructuring for Long-Term Gro - GuruFocus
Geron to cut workforce by one-third in strategic restructuring - Investing.com
Geron Corporation Announces Strategic Restructuring to Enhance RYTELO® U.S. Commercial Strategy and Reduce Operating Expenses - Quiver Quantitative
Geron (Nasdaq: GERN) plans one-third cut as 2026 operating expenses expected below 2025 - Stock Titan
Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today - MSN
Geron stock rating reiterated as Neutral by H.C. Wainwright - Investing.com
Geron (GERN) Highlights Promising ASH 2025 Data on RYTELO - GuruFocus
Geron reports early cytopenia may signal response in MDS patients - Investing.com
Geron Corporation Presents New Data on Imetelstat at ASH 2025, Highlighting Clinical Benefits in Lower-Risk Myelodysplastic Syndromes and Myelofibrosis - Quiver Quantitative
Geron (Nasdaq: GERN) presents ASH 2025 RYTELO data on LR-MDS cytopenias, survival trends - Stock Titan
How Geron Corporation (GON) stock correlates with oil marketsWeekly Gains Report & Daily Profit Focused Screening - Newser
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - Benzinga
What consensus target says about Geron Corporation (GON) stockJuly 2025 EndofMonth & High Conviction Buy Zone Picks - Newser
Will Geron Corporation (GON) stock keep raising dividends2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Why Geron Corporation (GON) stock stays on buy listsStop Loss & Daily Stock Trend Reports - Newser
Geron Corporation $GERN Stake Increased by Geode Capital Management LLC - MarketBeat
Great week for Geron Corporation (NASDAQ:GERN) institutional investors after losing 71% over the previous year - simplywall.st
Geron Corporation (NASDAQ:GERN) is favoured by institutional owners who hold 64% of the company - Yahoo Finance
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Wall Street Turns Bullish on Geron Corporation (GERN) amid Rytelo Sales Push Plans - Insider Monkey
10 Fastest Growing Penny Stocks to Buy Now - Insider Monkey
Geron Corporation (GERN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Market reaction to Geron Corporation’s recent newsPortfolio Update Summary & Daily Stock Momentum Reports - newser.com
Will Geron Corporation stock gain from lower inflationWeekly Trend Recap & Weekly High Potential Alerts - newser.com
Will Geron Corporation (GON) stock extend growth storyWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Why analysts maintain buy rating on Geron Corporation (GON) stockJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
0.80%
4.56%
자본화:
|
볼륨(24시간):